I 
119TH CONGRESS 
1ST SESSION H. R. 5239 
To amend the Public Health Service Act to expand research and education 
with respect to endometrial cancer, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 9, 2025 
Mr. DAVID SCOTT of Georgia (for himself, Ms. CLARKE of New York, Ms. 
BROWN, Mr. JOHNSON of Louisiana, Ms. MOORE of Wisconsin, Ms. NOR-
TON, Ms. SEWELL, and Mr. TONKO) introduced the following bill; which 
was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to expand research 
and education with respect to endometrial cancer, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Endometrial Cancer 
Research and Education Act of 2025’’. 
SEC. 2. FINDINGS. 
Congress finds the following: 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS
(1) Endometrial cancer is cancer of the lining 
of the uterus (or endometrium) and is the most com-
mon form of uterine cancer. 
(2) Endometrial cancer is the fourth most com-
mon cancer diagnosed in women, after breast, lung, 
and colon cancer. 
(3) Endometrial cancer mainly affects post-
menopausal women, with most women diagnosed be-
tween age 55 and 64. 
(4) Women with polycystic ovary syndrome 
(PCOS) and uterine leiomyoma have an increased 
risk of developing endometrial cancer. 
(5) Unlike most other types of cancer, the inci-
dence of endometrial cancer, particularly aggressive 
subtypes of such cancer, has been increasing in the 
United States among all women, particularly among 
African-American and Asian women, with a 2.5 an-
nual percent change for both groups. 
(6) In comparison to non-Hispanic White 
women, African-American women have significantly 
higher incidence rates of aggressive endometrial can-
cers. 
(7) Such incidence rates for Hispanic and Asian 
women are equal to or lower than such incidence 
rates for non-Hispanic White women. 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS
(8) Although non-Hispanic White women are 
more likely to be diagnosed with endometrial cancer 
in comparison to African-American women, the rate 
of mortality is higher for African-American women. 
(9) Currently, the cause of such disparity is un-
known. Researchers are proposing investigative stud-
ies that link this disparity to the relationship be-
tween delays in care, aggressive late-stage diagnosis, 
and the time between diagnosis and beginning treat-
ment protocol for their cancer type. These factors 
are often exacerbated by socioeconomic conditions 
that affect access to innovative treatment, treatment 
completion, patient-reported outcomes, and overall 
quality of life. 
SEC. 3. EXPANDING RESEARCH AND EDUCATION WITH RE-
SPECT TO ENDOMETRIAL CANCER. 
(a) NATIONAL INSTITUTES OF HEALTH.—Part B of 
title IV of the Public Health Service Act (42 U.S.C. 284 
et seq.) is amended by adding at the end the following: 
‘‘SEC. 409K. ENDOMETRIAL CANCER. 
‘‘(a) IN GENERAL.—The Director of NIH shall— 
‘‘(1) expand, intensify, and coordinate programs 
to conduct and support research with respect to 
endometrial cancer; 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(2) communicate to medical professionals and 
researchers, including through the endometrial can-
cer public education program established under sec-
tion 399V–8, the disparity in the diagnosis of 
endometrial 
cancer 
between 
African-American 
women and non-Hispanic White women and any new 
research relating to endometrial cancer; and 
‘‘(3) ensure that African-American women are 
represented in clinical trials conducted or supported 
by the National Institutes of Health with respect to 
endometrial cancer in appropriate proportion to inci-
dence rates of such cancer for African-American 
women. 
‘‘(b) COORDINATION WITH OTHER INSTITUTES.— 
The Director of NIH shall coordinate activities carried out 
by the Director pursuant to subsection (a) with similar 
activities carried out by— 
‘‘(1) the Director of the Eunice Kennedy Shriv-
er National Institute of Child Health and Human 
Development; 
‘‘(2) the Director of the National Institute on 
Minority Health and Health Disparities; and 
‘‘(3) the Director of the Office of Research on 
Women’s Health. 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(c) AUTHORIZATION
OF
APPROPRIATIONS.—For 
purposes of carrying out this section, there is authorized 
to be appropriated $1,000,000 for each of fiscal years 
2026 through 2028.’’. 
(b) CENTERS FOR DISEASE CONTROL AND PREVEN-
TION.—Part P of title III of the Public Health Service 
Act (42 U.S.C. 280g et seq.) is amended by adding at 
the end the following: 
‘‘SEC. 399V–8. ENDOMETRIAL CANCER PUBLIC EDUCATION 
PROGRAM. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, shall develop and disseminate to the public infor-
mational materials on endometrial cancer, including the 
incidence rate of such cancer, the risk factors for devel-
oping such cancer, the increased risk for ethnic minority 
women to develop such cancer, and the range of available 
treatments for such cancer. Any informational material 
developed pursuant to the previous sentence may be trans-
mitted to a nonprofit organization; institution of higher 
education; Federal, State, or local agency; or media entity 
for purposes of disseminating such material to the public. 
‘‘(b) INCLUSION.—The informational materials under 
subsection (a) shall include materials targeted toward Af-
rican-American women. 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(c) CONSULTATION.—In developing and dissemi-
nating informational materials under subsection (a), the 
Director of the Centers for Disease Control and Preven-
tion shall consult with the Administrator of the Health 
Resources and Services Administration. 
‘‘(d) AUTHORIZATION
OF
APPROPRIATIONS.—For 
purposes of carrying out this section, there is authorized 
to be appropriated such sums as may be necessary for 
each of fiscal years 2026 through 2028.’’. 
Æ 
VerDate Sep 11 2014 
18:23 Sep 15, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H5239.IH
H5239
ssavage on LAPJG3WLY3PROD with BILLS